相关实验视频

Updated: Jul 18, 2025

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

基因表达失调作为膀癌的潜在诊断和预后生物标志物

Fee-Wai Chin¹, Soon-Choy Chan², Abhi Veerakumarasivam³

¹Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia.

Diagnostics (Basel, Switzerland)

|August 26, 2023

概括

Homeobox基因失调与膀癌的进展和结果有关. 了解这些遗传变化可能会导致更好的诊断和预后工具,用于膀癌.

科学领域:

分子生物学分子生物学
在瘤学瘤学.
遗传学遗传学是一个

背景情况:

家庭盒基因是胚胎发育的关键调节者.
它们的失调与各种癌症有关,包括膀癌.
准确预测膀癌复发和进展仍然是一个挑战.

研究的目的:

审查 homeobox 基因表达在膀癌中的诊断和预后潜力.
强调在膀癌管理中需要使用非侵入性生物标志物.

主要方法:

关于在膀癌中 homeobox 基因表达的综合文献综述.
分析了将homeobox基因失调与临床结果联系起来的研究.
评估homeobox基因作为潜在的生物标志物.

主要成果:

家庭盒子基因失调与膀癌有关.
改变的homeobox基因表达与临床结果相关.
作为诊断和预后标志物,Homeobox基因显示出有希望的结果.

结论:

基因表达模式提供了关于膀癌行为的见解.
针对homeobox基因失调可以改善膀癌的诊断和预后.
需要进一步的研究来验证homeobox基因作为非侵入性生物标志物.

关键词:

生物标志物生物标志物膀癌:膀癌是一种癌症.诊断诊断诊断诊断诊断诊断家庭盒子基因的基因预后预后预后瘤发生的起源

更多相关视频

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...